Cervarix
Term · Oncology and biomedicine · MLC-T-ONC-001607
A vaccine that is no longer available in the United States but is still used in other countries to protect against infection with two types of human papillomavirus (HPV). Cervarix is used in females aged 9 to 25 years to protect against high-risk HPV types 16 and 18, which most often cause cervical cancer and lesions that may become cervical cancer. Cervarix may also prevent other HPV-related cancers. Also called recombinant human papillomavirus bivalent vaccine.
| Identifier | MLC-T-ONC-001607 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | recombinant human papillomavirus bivalent vaccine |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-001607",
"term": "Cervarix",
"field": "Oncology and biomedicine",
"definition": "A vaccine that is no longer available in the United States but is still used in other countries to protect against infection with two types of human papillomavirus (HPV). Cervarix is used in females aged 9 to 25 years to protect against high-risk HPV types 16 and 18, which most often cause cervical cancer and lesions that may become cervical cancer. Cervarix may also prevent other HPV-related cancers. Also called recombinant human papillomavirus bivalent vaccine.",
"synonyms": [
"recombinant human papillomavirus bivalent vaccine"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/cervarix/"
}
Record 4,625 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.